Buter Jan

Dept Med Oncol Amsterdam Univ Med Ctr

Claim

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 149 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

时间

引用量

主题

期刊级别

合作者

合作机构

Supplementary Figure S13 from Identification of Patients with Recurrent Glioblastoma Who May Benefit from Combined Bevacizumab and CCNU Therapy: A Report from the BELOB Trial

Lale Erdem-Eraslan,Martin J. van den Bent,Youri Hoogstrate,Hina Naz-Khan,Andrew Stubbs,Peter van der Spek,René Böttcher,Ya Gao,Maurice de Wit,Walter Taal,Hendrika M. Oosterkamp,Annemiek Walenkamp,Laurens V. Beerepoot,Monique C.J. Hanse,Jan Buter,Aafke H. Honkoop,Bronno van der Holt,René M. Vernhout,Peter A.E. Sillevis Smitt,Johan M. Kros,Pim J. French

openalex（2023）

Cited0Views0Bibtex

Supplementary Figure S2 from Identification of Patients with Recurrent Glioblastoma Who May Benefit from Combined Bevacizumab and CCNU Therapy: A Report from the BELOB Trial

openalex（2023）

Cited0Views0Bibtex

Supplementary Table S1 from Identification of Patients with Recurrent Glioblastoma Who May Benefit from Combined Bevacizumab and CCNU Therapy: A Report from the BELOB Trial

crossref（2023）

Cited0Views0Bibtex

Supplementary Figure S1 from Identification of Patients with Recurrent Glioblastoma Who May Benefit from Combined Bevacizumab and CCNU Therapy: A Report from the BELOB Trial

crossref（2023）

Cited0Views0Bibtex

Supplementary Figure S3 from Identification of Patients with Recurrent Glioblastoma Who May Benefit from Combined Bevacizumab and CCNU Therapy: A Report from the BELOB Trial

crossref（2023）

Cited0Views0Bibtex

Supplementary Table S3 from Identification of Patients with Recurrent Glioblastoma Who May Benefit from Combined Bevacizumab and CCNU Therapy: A Report from the BELOB Trial

crossref（2023）

Cited0Views0Bibtex

Supplementary Figure S10 from Identification of Patients with Recurrent Glioblastoma Who May Benefit from Combined Bevacizumab and CCNU Therapy: A Report from the BELOB Trial

openalex（2023）

Cited0Views0Bibtex

Identification of Patients with Recurrent Glioblastoma Who May Benefit from Combined Bevacizumab and CCNU Therapy: A Report from the BELOB Trial

Lale Erdem-Eraslan,Martin J. van den Bent,Youri Hoogstrate,Hina Naz-Khan,Andrew Stubbs,Peter van der Spek,Rene Bottcher,Ya Gao,Maurice de Wit,Walter Taal,Hendrika M. Oosterkamp,Annemiek Walenkamp,Laurens V. Beerepoot,Monique C. J. Hanse,Jan Buter,Aafke H. Honkoop,Bronno van der Holt,Rene M. Vernhout,Peter A. E. Sillevis Smitt,Johan M. Kros,Pim J. French

pubmed（2023）

Cited91Views0WOSBibtex

Supplementary Figure S12 from Identification of Patients with Recurrent Glioblastoma Who May Benefit from Combined Bevacizumab and CCNU Therapy: A Report from the BELOB Trial

crossref（2023）

Cited0Views0Bibtex

Supplementary Figure S11 from Identification of Patients with Recurrent Glioblastoma Who May Benefit from Combined Bevacizumab and CCNU Therapy: A Report from the BELOB Trial

openalex（2023）

Cited0Views0Bibtex

Author Statistics

#Papers: 151

#Citation: 6011

H-Index: 34

G-Index: 76

Sociability: 7

Diversity: 3

Activity: 6

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn